- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Frameworks for Advancing Health Equity: Health Equity by Design
Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.
This episode is another installment of the Managed Care Cast series Frameworks for Advancing Health Equity by the Center on Health Equity & Access, which highlights innovative programs developed in the health care space that are striving to address the health inequities and disparities that exist within the US health care system.
Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains the company's commitment to "Health Equity by Design" and how it ensures a personalized and intentional approach for all its members, regardless of race or ethnicity, sexual orientation, gender identity, disability, and geographic or financial access.
Frameworks for Advancing Health Equity episodes:
LGBTQIA+ Affirming Provider Designation
Trans and Gender Diverse Health Care
Listen above or on one of these podcast services:
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
